HSIC
Get informed when a big investor buys or sells
+ FollowOvervalued by 37.9% based on the discounted cash flow analysis.
| Market cap | $9.76 Billion |
|---|---|
| Enterprise Value | $13.61 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $3.29 |
| Beta | 0.84 |
| Outstanding Shares | 113,451,329 |
| P/E Ratio | 24.28 |
|---|---|
| PEG | 261.01 |
| Price to Sales | 0.72 |
| Price to Book Ratio | 2.09 |
| Enterprise Value to Revenue | 1 |
| Enterprise Value to EBIT | 18.37 |
| Enterprise Value to Net Income | 33 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 1.27 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 38.66% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.06%▼ 109.16% |
|---|---|
| Total Invested | $6.08M▼ 99.94% |
| Investors Holding | 20▼ 555.00% |
No data
Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 mi...